We are live on
!
Find out more
Primecap Management Portfolio holdings
AUM
$169B
Turnover
4.85%
1-Year Est. Return
114.72%
This Fund
S&P 500
This Quarter
Est. Return
+5.02%
1 Year Est. Return
+114.72%
3 Year Est. Return
+234.44%
5 Year Est. Return
+291.25%
10 Year Est. Return
+1,263.36%
AUM
$91.3B
AUM Growth
+$2.98B
(+3.4%)
Cap. Flow
-$825M
Cap. Flow
% of AUM
-0.9%
Top 10 Holdings %
Top 10 Hldgs %
34.96%
Holding
259
New
7
Increased
73
Reduced
140
Closed
5
Avg Time Held
0.9
years
Top 10 Avg Time Held
1
year
Top 20 Avg Time Held
0.9
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
United Airlines
UAL
|
+$144M |
| 2 |
Jacobs Solutions
J
|
+$83.6M |
| 3 |
CSX Corp
CSX
|
+$52.1M |
| 4 |
Ross Stores
ROST
|
+$51.1M |
| 5 |
Thermo Fisher Scientific
TMO
|
+$47.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
GSK
GSK
|
+$218M |
| 2 |
Electronic Arts
EA
|
+$134M |
| 3 |
FedEx
FDX
|
+$124M |
| 4 |
Medtronic
MDT
|
+$120M |
| 5 |
Visa
V
|
+$83.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.36% |
| 2 | Healthcare | 25.97% |
| 3 | Industrials | 13.99% |
| 4 | Miscellaneous | 7.28% |
| 5 | Consumer Discretionary | 6.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
126
Apple
AAPL
$4.99T
| $96.8M | 0.11% |
4,167,800
+56,000
| +1% | +$1.19M |
2013 Q2
4 quarters
|
|
|
127
CSX Corp
CSX
$90.2B
| $95.2M | 0.1% |
9,271,251
+5,348,700
| +136% | +$52.1M |
2013 Q2
4 quarters
|
|
|
AFFX
128
DELISTED
Affymetrix Inc
AFFX
| $94.1M | 0.1% |
10,559,240
-131,300
| -1% | -$1.05M |
2013 Q2
4 quarters
|
|
|
ELLI
129
DELISTED
Ellie Mae Inc
ELLI
| $94M | 0.1% |
3,020,900
+99,165
| +3% | +$2.66M |
2013 Q2
4 quarters
|
|
|
FEIC
130
DELISTED
FEI COMPANY
FEIC
| $93M | 0.1% |
1,024,719
+719
| +0.1% | +$63.3K |
2013 Q2
4 quarters
|
|
131
Charles River Laboratories
CRL
$14.6B
| $90.8M | 0.1% |
1,696,800
-1,000
| -0.1% | -$54.9K |
2013 Q2
4 quarters
|
|
132
DELISTED
Coterra Energy
CTRA
| $89.3M | 0.1% |
2,615,200
+195,000
| +8% | +$6.99M |
2013 Q2
4 quarters
|
|
133
Canadian Pacific Kansas City
CP
$76.4B
| $87.7M | 0.1% |
2,420,650
| – | – |
2013 Q2
4 quarters
|
|
|
ABAX
134
DELISTED
Abaxis Inc
ABAX
| $87.5M | 0.1% |
1,975,700
-3,600
| -0.2% | -$150K |
2013 Q4
2 quarters
|
|
135
DuPont de Nemours
DD
$17.8B
| $85.5M | 0.09% |
655,801
+7,286
| +1% | +$928K |
2013 Q2
4 quarters
|
|
136
PepsiCo
PEP
$175B
| $85M | 0.09% |
951,800
+205,000
| +27% | +$17.7M |
2013 Q2
4 quarters
|
|
137
DELISTED
Faro Technologies
FARO
| $83.9M | 0.09% |
1,708,500
+133,542
| +8% | +$6.11M |
2013 Q2
4 quarters
|
|
138
Jabil
JBL
$30.1B
| $80.8M | 0.09% |
3,866,000
-66,600
| -2% | -$1.24M |
2013 Q2
4 quarters
|
|
139
Ovintiv
OVV
$18.3B
| $79.9M | 0.09% |
673,572
-4,160
| -0.6% | -$482K |
2013 Q2
4 quarters
|
|
140
ExxonMobil
XOM
$718B
| $79M | 0.09% |
784,812
+30,000
| +4% | +$3.03M |
2013 Q2
4 quarters
|
|
141
Insulet
PODD
$9.62B
| $77.7M | 0.09% |
1,957,956
-8,800
| -0.4% | -$338K |
2013 Q2
4 quarters
|
|
142
Accuray
ARAY
$20.8M
| $76.5M | 0.08% |
8,690,700
-94,800
| -1% | -$821K |
2013 Q2
4 quarters
|
|
143
Expeditors International
EXPD
$25.8B
| $76.2M | 0.08% |
1,726,642
-204,400
| -11% | -$8.79M |
2013 Q2
4 quarters
|
|
144
Entegris
ENTG
$22.4B
| $71.9M | 0.08% |
5,233,950
-37,216
| -0.7% | -$442K |
2013 Q2
4 quarters
|
|
145
Descartes Systems
DSGX
$7.58B
| $71.6M | 0.08% |
4,992,990
-25,800
| -0.5% | -$350K |
2013 Q2
4 quarters
|
|
146
American Express
AXP
$212B
| $70.1M | 0.08% |
739,000
| – | – |
2013 Q2
4 quarters
|
|
147
FormFactor
FORM
$8.85B
| $66.5M | 0.07% |
7,993,218
| – | – |
2013 Q2
4 quarters
|
|
148
VF Corp
VFC
$6.68B
| $65.2M | 0.07% |
1,099,255
+374,461
| +52% | +$21.8M |
2013 Q2
4 quarters
|
|
149
Mastercard
MA
$540B
| $63.4M | 0.07% |
862,750
-4,000
| -0.5% | -$297K |
2013 Q2
4 quarters
|
|
150
DELISTED
Discover Financial Services
DFS
| $61.1M | 0.07% |
986,100
+467,600
| +90% | +$27.3M |
2014 Q1
1 quarter
|
|
Similar funds
Primecap Management's Q2 2014 Portfolio in Review
As of Q2 2014, Primecap Management held 259 positions worth $91.3B, up 3.4% from $88.4B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Trading was light in Q2 2014: portfolio turnover was 4.6%. Primecap Management opened 7 new positions and exited 5, leaving the 259-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 28% a quarter earlier, followed by Healthcare and Industrials.
- Primecap Management's largest Q2 2014 buy was Exact Sciences: 2,491,300 shares worth $42.4M.
- Primecap Management added most to United Airlines in Q2 2014, an estimated $144M increase.
- Primecap Management's biggest Q2 2014 reduction was GSK, cutting an estimated $218M.
- Primecap Management fully exited Akamai in Q2 2014, selling an estimated $4.77M.
- Primecap Management's ten largest holdings make up 35% of its $91.3B portfolio in Q2 2014.
- Primecap Management opened 7 new positions and closed 5 in Q2 2014.
- Primecap Management's portfolio value rose 3.4% quarter-over-quarter to $91.3B.
Based on Primecap Management's 13F filing for Q2 2014, filed 14 Aug 2014.